• Portola Pharmaceuticals R&D Exec to Retire contractpharma
    April 26, 2019
    Portola Pharmaceuticals, Inc.: Dr. John Curnutte, M.D., Ph.D., executive vice president and head of R&D, will retire on May 17, 2019, after more than eight years of service.
  • Eli Lilly’s President of Oncology to retire pharmafile
    June 07, 2018
PharmaSources Customer Service